Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE2307.00-39.25 (-1.67 % )
PREV CLOSE (Rs.) 2346.25
OPEN PRICE (Rs.) 2335.90
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 88849
TODAY'S LOW / HIGH (Rs.)2281.00 2397.40
52 WK LOW / HIGH (Rs.)1786.05 2767.1
NSE2309.20 -32.95 (-1.41 % )
PREV CLOSE(Rs.) 2342.15
OPEN PRICE (Rs.) 2335.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 2309.20 (270 )
VOLUME 456915
TODAY'S LOW / HIGH(Rs.) 2281.60 2400.00
52 WK LOW / HIGH (Rs.)1785.4 2766.2

Board Meetings

Source Date Board Meeting Date Details
22-Jul-2021 05-Aug-2021 Quarterly Results
17-May-2021 28-May-2021 Audited Results
19-Jan-2021 04-Feb-2021 Quarterly Results
27-Oct-2020 07-Nov-2020 Interim Dividend & Quarterly Results
26-Aug-2020 02-Sep-2020 IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2020 ,inter alia, to consider and approve allotment of 5,00,000 equity shares of Rs. 2/- each fully paid-up of the Company to the members of the Promoters / Promoter Group upon conversion of warrants issued to them at the meeting of the Board of Directors of the Company held on 7th November, 2019 and pursuant to a resolution passed by the shareholders of the Company at the Extra Ordinary General Meeting held on 24th October, 2019. & Preferential Issue of shares
29-Jul-2020 10-Aug-2020 Quarterly Results
05-Jun-2020 16-Jun-2020 Audited Results
20-Jan-2020 12-Feb-2020 Quarterly Results
24-Oct-2019 07-Nov-2019 Quarterly Results
20-Sep-2019 26-Sep-2019 IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/09/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, 26th September, 2019, inter-alia, to consider issuance of convertible warrants to promoters/ members of the promoter group of the Company on preferential basis, subject to the approval of the shareholders.